INTRODUCTION
Germinal centers (GCs) form within peripheral lymphoid organs to foster T cell-dependent stimulation of B cells that results in the production of high-affinity antibodies (1, 2) . To produce such antibodies, GC B (GCB) cells interact with follicular helper T (T fh ) cells to enable their activation and differentiation into plasma cells (3) (4) (5) . The T fh cell lineage is imprinted by expression of B cell lymphoma 6 (Bcl6), a transcription factor that represses alternative fates and promotes T fh cell differentiation and function (6) . Bcl6 promotes the expression of CXCR5 (7) (8) (9) , which controls the homing of T fh cells to the B cell follicle and GCs (10, 11) . Interleukin-6 (IL-6) and IL-21 contribute to T fh cell differentiation (12, 13) when naïve T cells are stimulated through their T cell receptor (TCR) and costimulatory molecules, such as ICOS (inducible costimulator) and CD28 (7, 14, 15) . T fh -mediated CD40L/CD40 signaling in the presence of IL-21 and IL-4 induces proliferation, isotype switching, and differentiation of B cells (16) (17) (18) (19) (20) .
The generation of autoantibodies and the development of autoimmune diseases can result not only from the activation of autoreactive T and B cells but also from a dysregulation of GC formation and maintenance by T fh cells (21, 22) . Limiting the number of T fh cells within GCs is critical to warding off the emergence of autoantibodies (23) (24) (25) . Thus, regulation of T fh cells is essential for limiting GC reactions against self-antigens and preventing autoimmunity (26, 27) .
Follicular regulatory T (T fr ) cells were found to limit the GC reaction and to reduce antibody production within B cell follicles in human tonsils (28) and in mice (29) . These cells were initially reported to express Bcl6, programmed cell death protein 1 (PD-1), and CXCR5, the canonical markers of T fh cells, as well as forkhead box P3 (Foxp3) and CD25, the canonical markers of regulatory T (T reg ) cells (30, 31) . T fr cells were first described as CD25 hi , similar to T reg cells (29, 32) , and T fr cells are characterized/purified according to this marker in most studies. Except for mice expressing a reporter gene of Foxp3 expression, there is no other physiological surface marker that allows one to separate live T fr cells from T fh cells. T fr cells were proposed to develop not only from thymus-derived T reg cells but also from Foxp3 − precursors in a PD ligand 1-dependent manner (33) .
How T fr cells control the GC reaction remains unclear. In vitro suppression assays showed that T fr cells suppress B and T fh cell responses, inhibiting B cell activation and class switch recombination and decreasing T fh cell production of cytokines such as IL-4 (34, 35) . T fr suppression of T fh cells has been reported to be dependent on cytotoxic T lymphocyte-associated protein 4 (36, 37) . Depletion of T fr cells in Bcl6 fl/fl × Foxp3 CRE mice had no impact on the size of the T fh cell or GCB cell compartments (38) . However, vaccinated T frdepleted mice have altered antigen-specific antibody responses, with significantly increased immunoglobulin A (IgA) levels and decreased avidity of IgGs against the immunogen, suggesting a qualitative role of T fr cells in antibody production (38) .
The antigen specificity of T fh and T fr cells is not well known, and diverging results have been reported regarding T fr cells. Concordant results showed that T fh cells are specific for the immunizing antigen (33, 39, 40) . In contrast, a previous study showed that T fr and T fh cells share TCRs specific for the immunizing antigen (33) , whereas a recent one reported oligoclonal expansions in T fh cells and a broad TCR usage in T fr cells from the same GCs (41) .
In this work, we identified T fr cells as a rare population of CD4
+ cells that do not express CD25 and likewise do not respond to IL-2. On the basis of a stringent characterization of T fr cells, we analyzed their transcriptome and compared it with that of T fh and T reg cells. Transcriptome studies clustered T fr cells with T fh cells rather than T reg cells and revealed a previously uncharacterized IL-1 axis in T fr cell suppression of T fh cells. Together, our work should prompt a reassessment of the biology of T fr cells based on their better characterization and highlights an IL-2/IL-1 dichotomy for T reg cell control of effector T (T eff ) cells versus T fr cell control of T fh cells.
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RESULTS
T fr and T fh cell response to IL-2
We investigated the in vivo response of T fh and T fr cells to IL-2. Mice expressing the green fluorescent protein (GFP) as a reporter gene of Foxp3 expression were injected with an adeno-associated virus coding for IL-2 (AAV-IL-2) that allows continuous production of IL-2 (42). Twenty-one days after AAV-IL-2 injection, mice were immunized or not immunized with ovalbumin (OVA), and their spleens were analyzed 10 (Fig. 1A) and numbers ( fig. S2 ) of splenic T reg cells, as previously reported (42) (43) (44) , irrespective of the immunization. The marked increase of T fh cells induced by immunization was reduced by IL-2 (Fig. 1B) . In contrast, whereas immunization had no impact on the proportion of T fr cells, IL-2 induced a significant decrease of their proportion in CD4 + cells (Fig. 1C) . The combined effects of IL-2 on T fh and T fr cells led to a decreased T fr /T fh ratio for both immunization and IL-2 treatment, alone or in combination (Fig. 1D) . T fr cells, we studied their suppressive activity in a classic in vitro assay investigating the inhibition of IL-4 and IL-21 production by T fh cells from immunized mice cocultured with B cells (34) . Adding T fr cells to these cocultures significantly decreased IL-4 production (Fig. 2D ) and almost completely suppressed IL-21 production (Fig. 2E) .
T fr cells do not express CD25
Because T fr cells were initially described as CD25 + (32), we speculated that this could be due to contamination by CXCR5 
Foxp3
+ cells (Fig. 2F, left) . Whereas CXCR5 hi PD-1 hi T fr cells homogeneously express Bcl6 and are CD25 − , the progressive decrease in the intensity of CXCR5 and PD-1 expression was associated with a parallel loss of Bcl6 expression and an increase in CD25 expression (Fig. 2F, middle and right) . These results indicate that a nonstringent characterization of T fr cells leads to the inclusion of T reg cells.
T fr cells' transcriptomic profile distinguishes them from T reg and T fh cells
We analyzed the expression profile of a set of 545 immune-related genes in T fh , T fr , and T reg cells from NOD and BALB/c mice using NanoString technology. Hierarchical clustering based on the entire set of genes clustered T reg cells samples apart from T fol cell samples ( fig. S5 ). We further used the 81 genes that better separate the three cell subsets (see the Supplementary Materials) to perform an additional hierarchical clustering (Fig. 3A ) that again identified two main clusters of T fol and T reg cells, regardless of the genetic background. Within the T fol cluster, T fr and T fh cells were well separated. We evaluated the accuracy and statistical robustness of this clustering by multiscale bootstrap resampling using the pvclust R package (Fig. 3B) (45, 46) . This statistical process attributes accuracy to each branch of the clustering by calculating an approximately unbiased (AU) P value as a percentage (45) . The higher the percentage, the higher the accuracy of a given branch of the clustering. In our data set, the AU P values for the separation of T reg and T fol cells, as well as for the separation of T fr and T fh cells within T fol cells, were 100%, indicating the robustness of the cell subset identification.
Differential gene expression in T reg , T fh , and T fr cells
We next analyzed the genes differentially expressed between T fh , T fr , and T reg cells using Ingenuity Pathway Analysis (IPA). The IPA's Upstream Regulator analytic tool identified NFATc1, a subunit of the NFAT (nuclear factor of activated T cells) complex known to interact with Foxp3 (47, 48) , as a key component differentiating the transcriptome profiles of our three cell populations. NFATc1 is down-regulated (blue) in T reg cells and up-regulated (orange) in T fh and T fr cells, in accordance with (i) the observed expression levels of genes regulated by NFATc1 and (ii) their expected positive or negative regulation by NFATc1 (49), as modeled by IPA. Foxp3 expression aside, the pattern of NFATc1-dependent gene expression was identical between T fh and T fr cells. In contrast, each of the NFATc1 up-regulated genes in T reg cells was down-regulated in T fr and T fh cells, and vice versa (Fig. 4A ).
IPA then identified the pathways differentially modulated between the cell subsets. T fr cells appeared as very active cells, with markedly up-regulated pathways related to movement, survival, viability, and proliferation. In contrast, pathways related to death and mortality were up-regulated in T fh cells (Fig. 4B) .
Supervised analyses then identified ILs and their receptors as markedly differentially expressed among the three cell subsets. IL-2R, IL-2R, and IL-2R are highly expressed by T reg cells, whereas T fr and T fh cells only express IL-2R and IL-2R (Fig. 4C, left) . IL-1Rs were not expressed by T reg cells and had distinct expression profiles for T fol subsets (Fig. 4C, right) . T fh cells only expressed the agonist IL-1 receptor IL-1R1, which transmits the inflammatory message of IL-1. In contrast, T fr cells expressed lower levels of IL-1R1 than T fh cells but high levels of IL-1R2, the IL-1 receptor decoy (50) , and, to a lesser extent, IL-1Rn, the IL-1R antagonist (51) .
IL-4 and IL-21, cytokines involved in T fh -mediated B cell help (16, 20, 52) , were mostly expressed by T fh cells ( fig. S6 ). IL-2 expression could not be detected in any of the subsets, whereas IL-1 expression was at the limit of detection (number of transcripts ≈ 100) and was similar in each subset ( fig. S6 ). Costimulation molecules involved in B-T cell cooperation were also differentially expressed in T fol cells. CD40L was mostly expressed on T fh cells, whereas OX40 ( fig. S6 ) was mostly expressed on T fr cells. Thus, the IL-1 receptors CD40L and OX40 are the main molecules that discriminate T fh and T fr cells, as also confirmed by flow cytometry for IL-1R2 and OX40 ( 
IL-1-dependent T fh cell activation
To assess the functional relevance of our IL-1-related gene expression profile, we investigated the role of IL-1 in T fh cells. We treated immunized mice with recombinant IL-1Ra (Anakinra), which blocks the IL-1 response in humans (53) and mice (54) (55) (56) , or with murine IL-1.
Compared with untreated immunized mice (OVA + Alum), inhibition of IL-1 during immunization led to a significantly reduced proportion of T fh cells (Fig. 5A ), whereas injection of IL-1 induced a significant increase of T fh cell proportion. This increase was observed even when immunization was performed without Alum, indicating the autonomous effect of IL-1 on T fh cells. The increased T fh cell response induced by IL-1 translated into an increased production of anti-OVA-specific IgG (Fig. 5B) .
We then tested the contribution of IL-1 to the production of IL-4 by T fh cells from immunized mice (Fig. 5C ). B cells alone did not produce IL-4, whereas baseline T fh cell IL-4 production was around 50 pg/ml. Coculture of B and T fh cells led to a doubling of IL-4 production, whereas the addition of IL-1 rather than B cells led to an even more pronounced increase of IL-4 production by T fh cells. Thus, T fh cells are directly activated by IL-1.
We next investigated the IL-1 dependence of the T fh cell suppression by T fr cells. When T fr cells (at a T fh /T fr ratio of 2) were added to a coculture of T fh and B cells, we observed a 50% reduction in IL-4 production ( Fig. 5D ), which corresponds to the value of basal IL-4 production by T fh cells (Fig. 5C ). This inhibition was equivalent to the inhibition observed when adding Anakinra (Fig. 5D ). This also suggests that some cells in the culture produced IL-1. We confirmed by flow cytometry that this production was mainly from B cells ( fig. S8 ). Similar results were observed for the production of IL-21, leading to a sevenfold decrease of IL-21 production when T fr cells are added to the culture (Fig. 5D) .
T fr cells could suppress the IL-1-induced T fh cell activation (Fig. 5E ). Whereas IL-1 led to a 10-fold increase of IL-4 and IL-21 production by T fh , the addition of T fr cells markedly inhibited this IL-1-dependent IL-4 and IL-21 production (Fig. 5E ). Together, these results indicate that there is an IL-1-dependent activation of T fh cells that can be suppressed by T fr cells.
T fr cell response to immunization with self-antigens or foreign antigens
We compared the response of T fr cells to antigenic stimulation with two representative antigens. OVA immunization led to a higher increase in T fh cells compared with insulin (INS) immunization (Fig. 6A) , and vice versa, for the proportion of T fr cells (Fig. 6B) . The resulting T fr / T fh ratio was thus about fourfold higher after immunization with a self-antigen compared with a foreign antigen (Fig. 6C ). This translated well in a higher proportion of CD19 (Fig. 6D) . There was an inverse correlation between the proportions of T fr cells and GCB cells (Fig. 6E) . When IL-1 was added during INS immunization, GCB cell values were in the range of those obtained after OVA immunization (Fig. 6F) , indicating that the lower expansion of GCB cells after INS immunization was not intrinsically limited by a lower frequency of INS-specific B cells. There was again an inverse correlation between the proportions of T fr cells and GCB cells (Fig. 6G) 
Phenotype of T fr cells in humans
We investigated the phenotype of T fh and T fr cells in humans by analyzing these cells in spleen or mesenteric lymph node cells obtained from healthy organ donors, or from tonsils. By using the same gating strategy that we used for mice (Fig. 7A) , we could show the absence of CD25 expression on human T fr cells (Fig. 7B) . As for mice, we analyzed CD25 expression on a gradient of subsets defined by the intensity of CXCR5 and PD-1 expression among CD4 +
Foxp3
+ cells (Fig. 7C,  left) . Although CXCR5 hi PD-1 hi T fr cells are homogeneously CD25 − , the progressive decrease in the intensity of CXCR5 and PD-1 expression was associated with a parallel increase in CD25 expression (Fig. 7C,  right) . As for mice, IL-1R2 was expressed only on T fr cells (Fig. 7D) .
DISCUSSION
IL-2 is now widely developed for stimulating T reg cells in the context of inflammatory and autoimmune diseases (57) . To better understand the consequences of an IL-2 treatment, and because T fr cells are thought to derive from T reg cells, we assessed T fr cell response to IL-2. We found that T fr cell proportion was reduced rather than augmented during IL-2 treatment. This intriguing observation led us to thoroughly assess their CD25 phenotype and to determine that T fr cells do not express CD25, neither in mice nor in humans. Contrary to T reg cells, which comprise both CD25 + and CD25 − subsets (58), careful investigations assessing expression of the canonical Bcl6 marker (Fig. 2F ) led us to conclude that T fr cells are homogeneously CD25
− and CXCR5 hi PD-1 hi . These results initially obtained in C57BL/6 mice were further confirmed in BALB/c and NOD mice ( fig. S3 ) and also observed for human T fr cells (Fig. 7C) . Although a recent study on T fr cell conditional depletion in Bcl6 fl/fl Foxp3 CRE mice suggested that T fr cells are CD25 lo rather than CD25 + (38), we believe that they are truly CD25 − , as also supported by their lack of expansion (Fig. 1C (61) . Such a reduction of IL-21 and IL-4 production has been described as the main mechanism by which T fr cells inhibit antibody responses (34) . The in vivo suppressive activity of CD25 − T fr cells is also supported by the observation that the sole elimination of Bcl6/ Foxp3 cells led to highly abnormal T fh cell and GCB cell responses (38) . As we show that our cells are the only Bcl6 + Foxp3 + cells (Fig. 2F) , this work strongly supports our conclusions. In vivo, the increase in T fr and T fh cells upon immunization was reciprocally dependent on the self/nonself nature of the antigen, suggesting different antigenic specificities, as recently reported (41) .
To further revisit T fr cell functionality on the basis of this previously unknown characterization, we studied the transcriptomic profile of T fr cells and compared it with that of T fh and T reg cells. We used the NanoString technology, which is reported to be more quantitative for small cell populations (62) . These analyses first showed that T fr cells were clustered with T fh and not with T reg cells (Fig. 3A and  fig. S5 ). This clustering was shown to be robust by a multiscale bootstrap sampling statistical validation (Fig. 3B) . This suggests that the transcriptional program controlled by Bcl6 imprints the transcriptome landscape of T fr cells more than the transcriptional program controlled by Foxp3. The first study describing T fr cells (29) showed a clustering of T fr cells with T reg cells; we believe that this could be due to contamination of the T fr cells by T reg cells. Our observation does not give clues as to the origin of T fr cells as cells either derived from thymic T reg cells or induced from T fh cells. The Bcl6-imprinted program could be secondarily imprinted over an initial imprinting by Foxp3, or vice versa. Lineage study and possibly TCR repertoire studies should help address this important issue.
We found that murine T fr cells highly express the decoy receptor IL-1R2 (Fig. 4C) . IL-1R2, an IL-1 and IL-1 negative regulator, has been observed on neutrophils, macrophages, monocytes, B cells, and CD4 + T cells (63) (64) (65) (66) . T fr cells also express IL-1Ra, the IL-1 receptor antagonist. We confirmed IL-1R2 expression on most, if not all, mouse and human T fr cells by flow cytometry (Figs. 4D and 7D ). IL-1R2 has also been described in some T reg cells after in vitro activation (65, 66) and in pancreatic (67) 7 of 11 (73) , which is highly expressed on T fh cells (fig. S6) ; and (iv) many adjuvants used for immunization are IL-1 inducers (74, 75) . These effects have been ascribed to IL-1, rather than to IL-1 (72) . These results, together with the observation that IL-1 alone activates T fh cells in vitro and in vivo, support the idea that our results should be relevant to all immunization procedures increasing IL-1 production. T fh and T fr cells are important for the regulation of humoral responses, in health and disease. Our results support that (auto)antibody production depends on IL-1 availability for T fh cells, regulated by IL-1 antagonists expressed by T fr cells. However, how general the contribution of the IL-1 axis is in the T fh /B cell response to various antigenic stimulations (such as against other foreign antigens or self-antigens and during infection or autoimmune diseases) remains to be investigated, because this was not explored in this study. The mechanisms at work for its regulation also remain to be dissected. Selective knockout of IL-1R1 and IL-1R2/IL-1Ra in T fh and T fr should help address these questions. Last, the lineage of T fr cells remains to be elucidated. Together, our results indicate a dual regulation of T cells in lymph nodes, one between T reg and T eff cells regulated by IL-2 outside GCs and the other between T fh and T fr cells regulated by IL-1 inside GCs.
MATERIALS AND METHODS
Study design
For human and mice flow cytometry assays, the sample sizes were of at least five individuals per experiment. For enzyme-linked immunosorbent assay (ELISA) and NanoString, sample sizes were of at least four per condition for which cells were sorted from pooled splenocytes from nine mice to ensure a sufficient number of T fr cells. Sample size was determined on the basis of experimental feasibility and for statistical significance. The experiments were not randomized. The investigators were not blinded to the allocation during experiments and analyses. 
Mice
IL-2 treatment in mice
AAV8-CAG-IL2 recombinant vectors (rAAVs) were generated by triple transfection of human embryonic kidney 293T cells, as described previously (42) . Mice were injected intraperitoneally once before immunization at day −21 (D−21) with 10 10 viral genomes of rAAVs diluted in 100 l of 1× phosphate-buffered saline (PBS1×).
Immunization
Mice were either immunized once (D0) and sacrificed at D10 for T fr /T fh phenotypic and transcriptomic studies or immunized twice (D0 and D14) and then euthanized at D28 for the analysis of GCB cells. Intraperitoneal injection was performed with 100 g of OVA (OVA A5503, Sigma-Aldrich) mixed with 500 g of aluminum hydroxide (Alum) gel (AlH303, Sigma) or with 4.5 IU of human INS (Umuline Rapide, Lilly) mixed with 500 g of Alum.
In vivo treatment
Mice treated with recombinant human IL-1Ra received Anakinra (1 mg per mouse; Amgen) every 24 hours from D−1 before immunization to D4 after immunization. Mice treated with IL-1 received recombinant mouse IL-1 (0.5 g per mouse; BioLegend) at D1 and D2 after immunization.
Flow cytometry analysis of mouse cells
Fresh total cells from lymph nodes and spleens were isolated in PBS1×-3% fetal bovine serum (FBS) and stained for 20 min at 4°C with the following monoclonal antibodies at predetermined optimal dilutions: CD121b-BV421, CD19-PeCF594, CD4-V500, CD8a-AF700, Bcl6-APC, CD278-BV421, CXCR5-Biotin (BD Biosciences), GL7-e450, Foxp3-AF488, PD-1-PE (PD-1-phycoerythrin), CD134-APC (CD134-allophycocyanin) (eBioscience), streptavidin-APC (eBioscience) or streptavidin-APC-Cy7 (BD Biosciences), CD25-PC7 (eBioscience), or CD25-eFluor 660 (BD Biosciences). CXCR5 staining was performed using biotinylated anti-CXCR5 for 30 min at 20°C followed by APC-or APC-Cy7-labeled streptavidin at 4°C. Intracellular detection of Foxp3 was performed on fixed and permeabilized cells using appropriate buffer (eBioscience), following the manufacturer's recommendations. Cells were acquired on an LSR II flow cytometer (Becton Dickinson) and analyzed using FlowJo software (TreeStar Inc.). Dead cells were excluded by forward/side scatter gating.
Human tissues
Human tissues were obtained from prospective organ donors through an approved research protocol (no. 2014-108) authorized by the French Biomedicine Agency and the Ministry of Education and Research. Relatives of the donors provided informed consent for the collection of samples. Tissues were collected after the organs were flushed with cold preservation solution.
Tissue samples were maintained in cold PBS and brought to the laboratory within 2 to 4 hours of organ procurement where they were rapidly processed using mechanical digestion, resulting in high yields of living lymphocytes. For the spleen, an additional step was carried out to isolate mononuclear cells by density gradient centrifugation with Lymphoprep (STEMCELL Technologies).
Flow cytometry analysis of human cells
Cell pellets were resuspended in a 10 6 cells/50 l of FBS concentration and then treated using the PerFix-nc kit (Beckman Coulter), following the manufacturer's recommendations. Cells were stained using a panel of fluorescence-conjugated fluorescein isothiocyanate (FITC), PE, PE-Texas Red (PE-TR), AF647, PE-Cy7, AF405, Pacific Blue, or BV510 monoclonal antibodies to detect the following cell proteins: CD4, CD25, CD127, Foxp3 (Beckman Coulter), CD3 (BD Biosciences), PD-1, CXCR5 (Ozyme), and IL-1R2 (R&D Systems). Flow cytometry data acquisition was performed on BD FACSAria II (BD Biosciences). Control samples included unstained and single fluorochrome-stained compensation beads (UltraComp eBeads, eBioscience). Flow cytometry data were analyzed using FlowJo software (TreeStar Inc.).
Cell sorting
Splenocytes from immunized mice were stained with Ter-119-biotin and B220-biotin antibodies for 20 min at 4°C and labeled with antibiotin magnetic beads (Miltenyi Biotec) for 15 min at 4°C. B cells and erythrocytes were depleted on an autoMACS separator (Miltenyi Biotec), following the manufacturer's procedure. Enriched T cells were stained as described in the "Flow cytometry analysis of human cells" section, and the following subsets were sorted on BD FACSAria II (BD Biosciences), with a purity of >98%: CD4 
Suppression assays
T fh , T fr , and CD19 + B cells were sorted from D−10 OVA-immunized mice, following a previously described "Immunization" protocol. For all the conditions, 2 × 10 4 T fh cells and 5 × 10 4 B cells were cultured for 96 hours in 96-well plates (Nunc) in complete RPMI 1640 (Thermo Scientific) with anti-IgM (5 g/ml; clone eB121-15F9, eBioscience) and three CD3/CD28 beads for one T cell (Dynabeads Mouse TActivator, Thermo Scientific). We then added either (i) 1 × 10 4 T fr cells with ("T fh + B + T fr + IL-1") or without ("T fh + B + T fr ") 1 g of recombinant mouse IL-1 (BioLegend), (ii) only 1 g of recombinant mouse IL-1 ("T fh + B + IL-1"), or (iii) Anakinra (500 ng/ml; Amgen) ("T fh + B + Anakinra"). IL-4 and IL-21 secretion levels were measured by ELISA (eBioscience) in supernatants of cultured cells, according to the manufacturer's recommendations.
Gene expression analysis based on a NanoString immunology panel Sorted cells were washed in PBS1× and stored in RNAqueous kit lysis buffer (Ambion Inc./Life Technologies) at −80°C. Total RNA was extracted according to the manufacturer's instructions, and quality was assessed on a bioanalyzer using the Pico RNA Reagent Kit (Agilent Technologies). Gene expression was analyzed using a NanoString mouse immunology panel, following the manufacturer's recommendation (see Supplementary Materials and Methods).
Statistical analysis
Flow cytometry, cytokine production, and gene expression data were analyzed using nonparametric Mann-Whitney U test on GraphPad Prism v5 [P values, such as P > 0.05 (not significant), *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, are indicated in the figures].
Exact P values are provided in table S1. Nonparametric correlation analyses were performed by Spearman rank correlation coefficient calculation. NanoString data were analyzed using IPA (QIAGEN). Clustering analysis and multiscale bootstrap resampling were performed using heatmap.2 and pvclust R packages on R version 3.1.3 (cluster method, average; distance, correlation).
See the Supplementary Materials for additional Materials and Methods information.
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